Healthcare giant Johnson & Johnson could soon buy heart device maker Shockwave Medical, the Wall Street Journal reported. The acquisition would be its second consecutive in the space in two years. The deal could be announced in the next few weeks, unless another suitor surfaces or if talks fall apart, sources familiar with the matter told the outlet. Johnson & Johnson’s last major acquisition was also in heart devices—Abiomed was added to the fold for for $16.6 billion in 2022. This new deal could rival it, as Shockwave currently has a market capitalization of $12 billion. Deals like these are part of a larger trend in the industry where pharma giants are expanding their heart treatment businesses.
Read the full article: Johnson & Johnson Is Reportedly Eyeing Its Second Big Heart Device Company Acquisition //
Source: https://qz.com/johnson-and-johnson-shockwave-medical-1851367580